-
1.发明申请PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE 审中-公开来自真菌或真菌的物理组合物及其使用方法公开(公告)号：US20070244175A1
公开(公告)日：2007-10-18
申请号：US11686033
申请日：2007-03-14
申请人： Robert Beelman , N. Dubost , Devin Peterson , Marvin Hausman
发明人： Robert Beelman , N. Dubost , Devin Peterson , Marvin Hausman
IPC分类号： A61K31/4166 , A01G1/04 , C07D233/28
CPC分类号： C07D233/02 , C07D233/66
摘要： This invention is directed to treating disease states or conditions associated with the treatment and prevention of neurodegeneration and neurodegenerative disease states, and treatment of radiation damage. The invention relates to novel phytonutrient compositions and compounds comprising L-ergothioneine and/or selenium. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof.
摘要翻译： 本发明涉及治疗与治疗和预防神经变性和神经变性疾病状态相关的疾病状态或病症，以及治疗辐射损伤。 本发明涉及新型植物营养素组合物和包含L-麦角硫素和/或硒的化合物。 本发明还提供了将这些组合物和组合施用于有需要的人或动物的方法。
-
2.发明申请PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE 审中-公开来自真菌或真菌的物理组合物及其使用方法公开(公告)号：US20090286839A1
公开(公告)日：2009-11-19
申请号：US12502677
申请日：2009-07-14
IPC分类号： A61K31/4164 , C07D233/02
CPC分类号： C07D233/02 , C07D233/66
摘要： This invention is directed to treating disease states or conditions associated with the treatment and prevention of neurodegeneration and neurodegenerative disease states, and treatment of radiation damage. The invention relates to novel phytonutrient compositions and compounds comprising L-ergothioneine and/or selenium. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof.
摘要翻译： 本发明涉及治疗与治疗和预防神经变性和神经变性疾病状态相关的疾病状态或病症，以及治疗辐射损伤。 本发明涉及新型植物营养素组合物和包含L-麦角硫素和/或硒的化合物。 本发明还提供了将这些组合物和组合施用于有需要的人或动物的方法。
-
3.发明授权Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias 失效用于治疗和诊断阿尔茨海默氏病和痴呆症的高选择性丁酰胆碱酯酶抑制剂公开(公告)号：US06683105B2
公开(公告)日：2004-01-27
申请号：US10071488
申请日：2002-02-07
IPC分类号： C07D48704
CPC分类号： A61K31/40 , A61K31/407 , C07D487/04 , C07D491/048 , C07D495/14
摘要： A method for treating cognitive impairments associated with aging or Alzheimer's disease which comprises treating a patient at risk for having the cognitive impairment with an effective amount of a highly selective butyrylcholinesterase inhibitor which is N8-benzylnorcymserine, N1-phenethylnorcymserine, N1, N8-bisnorcymserine, N1-N8-bisbenzylnorphysostigmine, N1, N8-bisbenzylnorphenserine, N1, N8-bisbenzylnorcymserine, or pharmaceutical acceptable salts thereof.
摘要翻译： 一种用于治疗与衰老或阿尔茨海默氏病相关的认知障碍的方法，其包括用有效量的高选择性丁酰胆碱酯酶抑制剂治疗具有认知障碍风险的患者，所述高度选择性丁酰胆碱酯酶抑制剂是N 8 - 苄基乳清丝氨酸，N，N-苯基氨基丝氨酸， N 1，N 8 - 双氰胺丝氨酸，N 1 -N 8 - 双苯基吗啉青霉素，N 1，N 8 - 苄基苯丙氨酸，N 1，N 8 - 苄基氰尿素或药物 其可接受的盐。
-
4.发明授权Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias 有权用于治疗和诊断阿尔茨海默氏病和痴呆症的高选择性丁酰胆碱酯酶抑制剂公开(公告)号：US06410747B1
公开(公告)日：2002-06-25
申请号：US09254494
申请日：1999-06-17
IPC分类号： C07D48704
CPC分类号： A61K31/40 , A61K31/407 , C07D487/04 , C07D491/048 , C07D495/14
摘要： A method for preventing or treating cognitive impairments associated with aging or Alzheimer's disease which comprises treating a patient at risk for having the cognitive impairment with an effective amount of a highly selective butyrylcholinesterase inhibitor.
摘要翻译： 一种用于预防或治疗与衰老或阿尔茨海默氏病相关的认知障碍的方法，其包括用有效量的高选择性丁酰胆碱酯酶抑制剂治疗具有认知障碍风险的患者。
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
